Jan-Paul Bohn

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Chronic Lymphocytic Leukemia

Prognostic Factors

Cardiac Surgery

Top Venues

American journal of hematology

Clinical kidney journal

This page only lists publications with an associated author ORCID identifier.

Publications

Clemens Plattner, Sebastian Sallaberger, Jan-Paul Bohn, Claudia Zavadil, Felix Keller, Afschin Soleiman, Martin Tiefenthaler, Gert Mayer, Markus Pirklbauer
Rationale and design of the Innsbruck Diabetic Kidney Disease Cohort (IDKDC)-a prospective study investigating etiology and progression of early-stage chronic kidney disease in type 2 diabetes. Clinical kidney journal 17 (5) (2024)
Clemens Plattner, Sebastian Sallaberger, Jan-Paul Bohn, Claudia Zavadil, Felix Keller, Afschin Soleiman, Martin Tiefenthaler, Gert Mayer, Markus Pirklbauer
Rationale and design of the Innsbruck Diabetic Kidney Disease Cohort (IDKDC)-a prospective study investigating etiology and progression of early-stage chronic kidney disease in type 2 diabetes. Clinical kidney journal 17 (5) (2024)
Florian Simon, Jan-Paul Bohn
Next-Generation Sequencing-Optimal Sequencing of Therapies in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL). Current oncology reports (2023)
Jan-Paul Bohn, Sabrina Neururer, Markus Pirklbauer, Andreas Pircher, Dominik Wolf
Hairy Cell Leukemia Patients Have a Normal Life Expectancy-A 35-Year Single-Center Experience and Comparison with the General Population. Cancers 14 (5) (2022)
Jan-Paul Bohn, Sascha Dietrich
Treatment of Classic Hairy Cell Leukemia: Targeting Minimal Residual Disease beyond Cladribine. Cancers 14 (4) (2022)
Jan-Paul Bohn, Anna Fiala, Sebastian Bachmann, Christian Irsara, Dominik Wolf, Clemens Feistritzer
Major cardiac surgery with recombinant FIX Fc fusion protein replacement in hemophilia B: a case report. Therapeutic advances in hematology 13 (2022)
Jan-Paul Bohn
Agony of choice-selecting chronic lymphocytic leukemia treatment in 2022. Memo 15 (2) (2022)
Jan-Paul Bohn, Stefan Salcher, Andreas Pircher, Gerold Untergasser, Dominik Wolf
The Biology of Classic Hairy Cell Leukemia. International journal of molecular sciences 22 (15) (2021)
Patrizia Mondello, Caterina Musolino, Irene Dogliotti, Jan-Paul Bohn, Federica Cavallo, Simone Ferrero, Barbara Botto, Claudio Cerchione, Davide Nappi, Sonya De Lorenzo, Giovanni Martinelli, Dominik Wolf, Clemens Schmitt, Giacomo Loseto, Salvatore Cuzzocrea, Wolfgang Willenbacher, Michael Mian, David J Straus
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study. American journal of hematology 95 (9) (2020)
Jan-Paul Bohn, Vera Reinstadler, Georg Pall, Günther Stockhammer, Michael Steurer, Herbert Oberacher, Dominik Wolf
Cerebrospinal Fluid Drug Concentrations and Clinical Outcome of Patients with Neoplastic Meningitis Treated with Liposomal Cytarabine. European journal of drug metabolism and pharmacokinetics 44 (6) (2020)
Jan-Paul Bohn, Andreas Pircher, David Wanner, David Vill, Bernhard Foeger, Dominik Wolf, Michael Steurer
Low-dose vemurafenib in hairy cell leukemia patients with active infection. American journal of hematology 94 (6) (2019)
Jan-Paul Bohn, Michael Steurer
Current and evolving treatment strategies in adult immune thrombocytopenia. Memo 11 (3) (2018)